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Plants represent an important source of diverse biomolecules with 
unique properties, some of which make them attractive candidates 
for the development of novel antimicrobials. Plant extracts have 
been evaluated in vitro for their activity against human-infecting 
gastrointestinal protozoa, such as Giardia intestinalis [1] and 
Entamoeba histolytica [2], with some success. Some plant extracts 
are also active against the sexually transmitted parasite Trichomonas 
vaginalis [2]. 
For the treatment of infections with microaerophilic protozoa, 
such as Dientamoeba fragilis and G. intestinalis, metronidazole 
(Flagyl®) has been the drug of choice for decades. However, it is well 
established that the widespread use of monotherapeutic treatment 
regimens encourages drug resistance, leading to treatment failures and 
relapses of illness. Recently, resistance to Flagyl® has been observed in 
T. vaginalis [3] and G. intestinalis [4], and has been suggested in the 
bowel parasite; D. fragilis, due to the increasing frequency of treatment 
failures [5]. With the emergence of drug resistance, there is increasing 
pressure to identify new drugs. In response to reports of possible Flagyl® 
resistance in D. fragilis [5], a simple study was designed to determine 
whether non-prescription dry plant extracts commercially available 
from local health stores exhibit direct anti-Dientamoeba activity. 
Dry plant extracts were selected based on reports of their 
antibacterial, antiprotozoal, and/or anthelmitic activity. The agents 
were also selected, as they are prescribed by many alternate health 
practioners as effective treatment for dientamoebiasis. The products 
evaluated included pomegranate (Punica granatum) peel extract, 
Garlic (Allium sativa) extract (crushed tablets), Goldenseal (Hydrastis 
candensis) extract (crushed tablets), Black Walnut (Juglans nigra) 
extract (crushed tablets), Wormwood (products from two species; 
Artemesia annua and Artemisis absinthium) each in crushed tablet form, 
Wormseed (Chenopodium ambrosioides) extract (crushed tablets), 
Pumpkin seeds (Cucurbita sp.) ground to fine powder, Grapefruit seed 
extract (powdered) and Ginger root extract (powdered).
Four clinical isolates of D. fragilis were used in this study. 
Dientamoeba trophozoites were cultured in a biphasic Loefflers 
medium overlayed with PBS and supplemented with 2 mg of rice 
starch [6]. The plant extracts were dissolved or suspended in the PBS 
overlay, at a concentration of 500 µg/ml, resulting in 10 different media 
formulations (one for each of the plant extracts). Media vials were 
inoculated with trophozoites of D. fragilis and incubated at 37°C under 
microaerophilic conditions. Cultures were examined microscopically 
on a daily basis for several days, for the presence or absence of motile D. 
fragilis trophozoites. Each experiment was accompanied by a negative 
control consisting of trophozoites inoculated into the standard Loffler’s 
slope medium. This experiment was repeated for each of the four D. 
fragilis isolates. Upon completion of this experiment, it was found that 
even at 500 µg/ml, none of these plant extracts had an inhibitory effect 
on D. fragilis growth. Motile trophozoites were still present after several 
days (as per negative controls).
While plant derived biomolecules show promise for the 
development of novel antiprotozoals, it must be remembered that 
the beneficial properties ascribed to plants are often attributable to 
a few select molecules. Usually, these molecules must be properly 
extracted and sufficiently concentrated to see any beneficial effects 
when administered. In the case of dry extracts, it can be difficult (or 
impossible) to administer a sufficient quantity to see any benefits at all. 
The plant extracts used in this study have no activity against cultured 
D. fragilis trophozoites at a concentration of 500 µg/ml, which exceeds 
that which could be achieved in the human body. However, based on 
the results of this study, it cannot be concluded that the plants evaluated 
do not possess anti-Dientamoeba activity. Rather, it is suggested that 
these dry plant extracts are ineffective. This finding is important for 
those considering natural, non-prescription therapies for treating 
gastrointestinal ailments in the place of conventional medicines.
Given that T. vaginalis and D. fragilis are both trichomonads, and 
that berberine salts from Goldenseal [7] and Pomegranate juice [8] are 
active against T. vaginalis, it was hypothesised that dry extracts from 
these plants would also possess anti-Dientamoeba activity. Similarly, 
Histomonas meleagridis is the closest known relative of D. fragilis [9], 
and essential oils extracted from garlic leaves possess anti-Histomonas 
activity [10], while powdered garlic extracts did not eradicate D. fragilis. 
The inability of the products used in this study to eradicate D. fragilis 
may be due to differences between the extracts used. For example, in 
this study dry plant extracts were used, while essential oil extracts [10], 
and purified berberine sulphate derived from Goldenseal [7], were used 
in studies involving other trichomonads.
To conclude, we demonstrate that various dry plant extracts 
available from local health stores are ineffective at eradicating cultured 
D. fragilis, for the first time. This does not confirm that these plants do 
not possess molecules capable of eradicating D. fragilis. Rather, it is 
concluded that dry extracts from commercial health product suppliers 
are ineffective. It is suggested that different types of extracts from the 
plants used in this study (such as lipid or organic solvent extracts) be 
evaluated for anti-Dientamoeba activity in future studies.
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